Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-08 Sale |
2022-04-12 4:05 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
172,520 | $0.57085 | $98,482 | 2,546,408 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 5:58 pm |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
11,664 | $0.7775 | $9,069 | 70,320 (Direct) |
View |
| 2022-02-03 Sale |
2022-02-03 5:56 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
52,056 | $0.7256 | $37,772 | 16,839,096 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 5:54 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
10,416 | $0.7562 | $7,877 | 15,826,160 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 7:53 pm |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
11,672 | $0.6588 | $7,690 | 81,984 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 7:52 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
52,056 | $0.6411 | $33,373 | 16,845,352 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 7:51 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
10,416 | $0.6453 | $6,721 | 15,991,120 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-09 8:58 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
17,656 | $0.7524 | $13,284 | 17,352,256 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 8:12 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
34,400 | $0.75246 | $25,884 | 17,369,912 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-03 9:45 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
10,416 | $0.767 | $7,989 | 16,456,384 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:07 pm |
Verona Pharma plc | VRNA | Ullman Anders Director |
12,056 | $0.8397 | $10,123 | 334,856 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:07 pm |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
10,680 | $0.8397 | $8,968 | 105,320 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:06 pm |
Verona Pharma plc | VRNA | Cunningham Kenneth Director |
13,112 | $0.8397 | $11,010 | 66,584 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:05 pm |
Verona Pharma plc | VRNA | Sinha Vikas Director |
10,016 | $0.8397 | $8,410 | 74,440 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:04 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
11,184 | $0.8397 | $9,391 | 684,643 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:04 pm |
Verona Pharma plc | VRNA | Edwards Martin Director |
12,024 | $0.8397 | $10,097 | 111,064 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 5:03 pm |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
10,680 | $0.8397 | $8,968 | 73,080 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 4:06 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
52,056 | $0.8054 | $41,926 | 17,859,160 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 4:06 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
10,416 | $0.8731 | $9,094 | 16,921,640 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:05 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
26,728 | $1.1438 | $30,571 | 19,054,504 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-28 Option Award |
2022-04-29 4:44 pm |
N/A 2032-04-27 |
Verona Pharma plc | VRNA | Edwards Martin Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 4:42 pm |
N/A 2032-04-27 |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 06:04 am |
N/A 2032-03-13 |
Verona Pharma plc | VRNA | Brady James Aloysius Director |
288,000 | $0 | 288,000 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 5:57 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
63,560 | $0.7762 | 2,718,928 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 5:56 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
288,648 | $0.7763 | 16,839,096 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:56 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
334,448 | $0.7475 | 16,839,096 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 5:55 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
79,896 | $0.7763 | 2,406,687 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 5:54 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
288,320 | $0.7762 | 15,826,160 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 5:54 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
133,776 | $0.7475 | 15,826,160 (Direct) |
View |
| 2021-11-01 Tax Withholding |
2021-11-03 7:53 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
56,928 | $0.64 | 2,782,488 (Direct) |
View |
| 2021-11-01 Tax Withholding |
2021-11-03 7:52 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
454,848 | $0.64 | 16,845,352 (Direct) |
View |
| 2021-11-01 Tax Withholding |
2021-11-03 7:51 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
79,896 | $0.64 | 2,486,583 (Direct) |
View |
| 2021-11-01 Tax Withholding |
2021-11-03 7:51 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
454,848 | $0.64 | 15,991,120 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:47 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Sinha Vikas Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:46 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:46 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Edwards Martin Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:45 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:44 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:43 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Cunningham Kenneth Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:43 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:42 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Sinclair Andrew Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:41 pm |
N/A 2031-08-08 |
Verona Pharma plc | VRNA | Ullman Anders Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-04 8:12 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
454,848 | $0.785 | 17,369,912 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-04 7:41 pm |
N/A N/A |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
11,664 | $0.785 | 93,656 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-03 10:00 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
227,736 | $0.785 | 2,839,416 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-03 9:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
319,600 | $0.785 | 2,566,479 (Direct) |
View |
| 2021-08-01 Gift |
2021-08-03 9:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
360,400 | $0 | 2,566,479 (Direct) |
View |
| 2021-08-01 Tax Withholding |
2021-08-03 9:45 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
454,840 | $0.785 | 16,456,384 (Direct) |
View |
| 2021-05-03 Tax Withholding |
2021-05-05 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
2,139,632 | $0.8875 | 17,859,160 (Direct) |
View |
| 2021-05-03 Tax Withholding |
2021-05-05 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
2,122,448 | $0.8875 | 16,921,640 (Direct) |
View |